No Data
No Data
Market Still Lacking Some Conviction On Xiangyu Medical Co.,Ltd (SHSE:688626)
Xiangyu Medical (688626.SH): Suzhou Jifeng, Jiaxing Jifeng No. 1, and Fuzhou Jifeng all did not reduce their shareholding in the company.
On September 10th, Gelonghui announced that Xiangyu Medical (688626.SH) received a notice on the expiration of the shareholding reduction plan and the results of the reduction from its shareholders, Suzhou Jifeng, Jiaxing Jifeng No.1, and Fuzhou Jifeng. As of September 10th, 2024, Suzhou Jifeng, Jiaxing Jifeng No.1, and Fuzhou Jifeng have not reduced their shareholding in the company. The shareholding reduction plan has come to an end upon its expiration.
Xiangyu Medical 2024 Semi-Annual Report
Summary of the 2024 Semi-Annual Report of Xiangyu Healthcare
Xiangyu Medical (688626.SH) released its semi-annual performance with a net income of 56.64 million yuan, a year-on-year decrease of 47.37%.
Xiangyu Medical (688626.SH) disclosed its 2024 interim report, with the company achieving a revenue of 3.38...
Shandong Xiangyu Medical (688626.SH): net income of 56.6359 million yuan in the first half of the year, a year-on-year decrease of 47.37%.
On August 29th, Xiangyu Medical (688626.SH) announced its semi-annual report. During the reporting period, the company achieved a revenue of 337.8593 million yuan, a year-on-year growth of 0.93%; achieved a net income attributable to the owners of the parent company of 56.6359 million yuan, a year-on-year decrease of 47.37%; achieved a net income attributable to the owners of the parent company after deducting non-recurring gains and losses of 53.4371 million yuan, a year-on-year decrease of 43.62%. At the end of the reporting period, the company's total assets were 2,657.0781 million yuan, a year-on-year increase of 2.51%; net assets attributable to shareholders of the listed company were 201 million yuan.
No Data
No Data